Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine + Cytarabine vs High-Dose Cytarabine in AML1-ETO AML
NCT02024308Phase 4Unknown
- Sponsor
- Changhai Hospital
- Start
- Nov 2010
- Primary completion
- Nov 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of fludarabine in acute myeloid leukemia (AML), sponsored by Changhai Hospital. Status: unknown.
02
Drugs
fludarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02024308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02024308.